Paradigm Biocapital Advisors LP PCVX Holdings History
Paradigm Biocapital Advisors LP's Vaxcyte Inc Holding Summary
As of 2025-03-31, Paradigm Biocapital Advisors LP held 1.70 Mil shares of Vaxcyte Inc(PCVX), totaling $64.06 Mil. This investment constitutes 2.93% of their stock portfolio, and Paradigm Biocapital Advisors LP now holds 1.32% of the outstanding Vaxcyte Inc(PCVX) stock.
The initial trade took place in 2024Q1. And since then Paradigm Biocapital Advisors LP has made 4 purchases of PCVX, at an average price of $80.78, for a total of 2.31 Mil shares. In addition, there have been 1 sales at an average price of $68.07 for 612,793.00 shares. Based on historical transaction data and PCVX's current price of $32.54, Paradigm Biocapital Advisors LP's estimated gain on his PCVX holdings is $-89.63 Mil, reflecting a -48.05% gain to date.
Paradigm Biocapital Advisors LP PCVX ($32.54) Holding Chart
Paradigm Biocapital Advisors LP PCVX ($32.54) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1